Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 6/18/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Timothy Timm Crowder

Wrong Dr. Timothy Timm Crowder?

Vice President of Technical Opera...

Spyryx Biosciences
 
Background

Employment History

Board Memberships and Affiliations

Education

  • Ph.D.
    UNC
  • degrees , physics
    Davidson College
  • degrees , physics
    North Carolina State University
12 Total References
Web References
Research Triangle Park, N.C. -- Timothy ...
ltw.m0bl.net, 18 June 2015 [cached]
Research Triangle Park, N.C. -- Timothy "Timm" Crowder, Ph.D., an entrepreneurial expert in design and development of inhaler technologies for lung therapies, has joined pharmaceutical startup Spyryx Biosciences as vice president of technical operations.
Crowder joined Spyryx from GlaxoSmithKline, where he was most recently director of advanced manufacturing technology at the GSK manufacturing facility in Zebulon.
In his new role reporting to Spyryx president and CEO John Taylor, Crowder is responsible for inhalation delivery technologies for the company's pulmonary therapeutics, and for overseeing manufacturing and supply chain strategies for them.
...
Before Crowder joined GSK, he was a co-founder of Oriel Therapeutics, a Durham-based inhaler technology company built around device designs he developed during his graduate research. He earned his Ph.D. from UNC and has degrees in physics from North Carolina State University and Davidson College.
Timothy "Timm" Crowder, Ph.D. -- Spyryx ...
www.ncbiotech.org, 17 June 2015 [cached]
Timothy "Timm" Crowder, Ph.D. -- Spyryx photo
Timothy "Timm" Crowder, Ph.D., an entrepreneurial expert in design and development of inhaler technologies for lung therapies, has joined pharmaceutical startup Spyryx Biosciences as vice president of technical operations.
Crowder joined Spyryx from GlaxoSmithKline, where he was most recently director of advanced manufacturing technology at the GSK manufacturing facility in Zebulon.
In his new role reporting to Spyryx president and CEO John Taylor, Crowder is responsible for inhalation delivery technologies for the company's pulmonary therapeutics, and for overseeing manufacturing and supply chain strategies for them.
...
Before Crowder joined GSK, he was a co-founder of Oriel Therapeutics, a Durham-based inhaler technology company built around device designs he developed during his graduate research. He earned his Ph.D. from UNC and has degrees in physics from North Carolina State University and Davidson College.
Oriel Therapeutics: Leadership
www.orieltherapeutics.com, 27 April 2007 [cached]
Timothy M. Crowder, PhD - Vice President, Powder Technology
...
Timothy M. Crowder, PhD - VP, Oriel Therapeutics, Inc.
...
Timothy M. Crowder, PhD - Vice President, Powder Technology and FounderTimm's dissertation research, concerning the physics of powder flow and its application to dispersion in dry powder inhalers, forms the basis for Oriel's technology platform.His research at UNC included the direction of an industrially-sponsored nasal dry powder vaccine project and developing a prototype dry powder inhaler and dispersion mechanism.Dr. Crowder completed his Ph.D. in the Department of Biomedical Engineering at the University of North Carolina, Chapel Hill under the supervision of Professor Anthony Hickey.
NCBiotech News | North Carolina Biotech Center
www.ncbiotech.org, 4 Dec 2010 [cached]
Timothy "Timm" Crowder, Ph.D., an entrepreneurial expert in design and development of inhaler technologies for lung therapies, has joined pharmaceutical startup Spyryx Biosciences as vice president of technical operations.
Dr. Timothy Crowder, of Oriel ...
triangle.triangle.dbusinessnews.com, 23 June 2005 [cached]
Dr. Timothy Crowder, of Oriel Therapeutics, to present at the Montreal Particulate Processes in the Pharmaceutical Industry Conference
...
Dr. Timothy Crowder, of Oriel Therapeutics, to present at the Montreal Particulate Processes in the Pharmaceutical Industry Conference
...
Dr. Timothy Crowder, of Oriel Therapeutics, to present at the Montreal Particulate Processes in the Pharmaceutical Industry Conference
Triangle -
Durham - Dr. Timothy Crowder of Oriel Therapeutics will be presenting recent research findings at the Particulate Processes in the Pharmaceutical Industry Conference.
...
Crowder is a founder of Oriel Therapeutics.He completed his Ph.D. in the Department of Biomedical Engineering at the University of North Carolina, Chapel Hill.His dissertation research, concerning the physics of powder flow and its application to dispersion in dry powder inhalers, forms the basis for Oriel's technology platform.His research at UNC included the direction of an industrially-sponsored nasal dry powder vaccine project and developing a prototype dry powder inhaler and dispersion mechanism.
Other People with the name "Crowder":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.